Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
Ownership |
2021-04-09 4:36 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Wang Lai Global Head of R&D |
0 | $0 | 2,885,987 (Direct) |
View |
| 2021-03-29 Exercise |
2021-03-31 4:46 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Huang Jane CMO, Hematology |
1,500 | $29.49 | 551,658 (Direct) |
View |
| 2021-03-29 Exercise |
2021-03-31 4:46 pm |
N/A 2026-09-02 |
BeiGene Ltd. | BGNE | Huang Jane CMO, Hematology |
19,500 | $0 | 551,658 (Direct) |
View |
| 2021-03-12 Gift |
2021-03-16 4:31 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Glazer Donald W. Director |
80,000 | $0 | 2,827,829 (Direct) |
View |
| 2021-02-26 Exercise |
2021-03-02 4:52 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Huang Jane CMO, Hematology |
1,500 | $29.49 | 571,158 (Direct) |
View |
| 2021-02-26 Exercise |
2021-03-02 4:52 pm |
N/A 2026-09-02 |
BeiGene Ltd. | BGNE | Huang Jane CMO, Hematology |
19,500 | $0 | 571,158 (Direct) |
View |
| 2021-01-29 Exercise |
2021-02-02 4:49 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Huang Jane CMO, Hematology |
1,500 | $29.49 | 590,658 (Direct) |
View |
| 2021-01-29 Exercise |
2021-02-02 4:49 pm |
N/A 2026-09-02 |
BeiGene Ltd. | BGNE | Huang Jane CMO, Hematology |
19,500 | $0 | 590,658 (Direct) |
View |
| 2021-01-14 Exercise |
2021-01-19 5:04 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Liang Howard CFO & Chief Strategy Officer |
14,000 | $6.5 | 3,035,515 (Direct) |
View |
| 2021-01-14 Exercise |
2021-01-19 5:04 pm |
N/A 2025-07-01 |
BeiGene Ltd. | BGNE | Liang Howard CFO & Chief Strategy Officer |
182,000 | $0 | 3,035,515 (Direct) |
View |
| 2020-12-29 Exercise |
2020-12-30 4:34 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Huang Jane CMO, Hematology |
1,500 | $29.49 | 610,158 (Direct) |
View |
| 2020-12-29 Exercise |
2020-12-30 4:34 pm |
N/A 2026-09-02 |
BeiGene Ltd. | BGNE | Huang Jane CMO, Hematology |
19,500 | $0 | 610,158 (Direct) |
View |
| 2020-12-18 Option Award |
2020-12-18 9:25 pm |
N/A N/A |
BeiGene Ltd. | BGNE | AMGEN INC 10% Owner |
25,762 | $260.95 | 18,778,273 (Direct) |
View |
| 2020-12-17 Option Award |
2020-12-17 9:18 pm |
N/A N/A |
BeiGene Ltd. | BGNE | AMGEN INC 10% Owner |
74,624 | $260.54 | 18,752,511 (Direct) |
View |
| 2020-12-15 Option Award |
2020-12-17 9:18 pm |
N/A N/A |
BeiGene Ltd. | BGNE | AMGEN INC 10% Owner |
67,941 | $239.31 | 18,752,511 (Direct) |
View |
| 2020-12-16 Option Award |
2020-12-17 9:18 pm |
N/A N/A |
BeiGene Ltd. | BGNE | AMGEN INC 10% Owner |
85,573 | $248.26 | 18,752,511 (Direct) |
View |
| 2020-12-15 Gift |
2020-12-17 4:45 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Wang Xiaodong Chair, Scientific Advisory Brd |
165,295 | $0 | 11,374,124 (Direct) |
View |
| 2020-12-14 Exercise |
2020-12-16 4:43 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Liang Howard CFO & Chief Strategy Officer |
91,900 | $6.5 | 831,000 (Direct) |
View |
| 2020-12-14 Exercise |
2020-12-16 4:43 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Liang Howard CFO & Chief Strategy Officer |
1,405,300 | $0.5 | 831,000 (Direct) |
View |
| 2020-12-14 Exercise |
2020-12-16 4:43 pm |
N/A 2025-07-01 |
BeiGene Ltd. | BGNE | Liang Howard CFO & Chief Strategy Officer |
2,600,000 | $0 | 831,000 (Direct) |
View |
| 2020-12-11 Gift |
2020-12-15 5:09 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN Chief Executive Officer |
2,136,914 | $0 | 54,605,483 (Direct) |
View |
| 2020-12-10 Gift |
2020-12-14 4:55 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Wang Xiaodong Chair, Scientific Advisory Brd |
1,332,552 | $0 | 11,539,419 (Direct) |
View |
| 2020-12-04 Gift |
2020-12-08 4:50 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Glazer Donald W. Director |
589,849 | $0 | 2,907,829 (Direct) |
View |
| 2020-10-13 Gift |
2020-12-04 5:24 pm |
N/A N/A |
BeiGene Ltd. | BGNE | BAKER BROS. ADVISORS LP 667 L.P. Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Director 10% Owner |
13,516 | $0 | 10,858,642 (Direct) |
View |
| 2020-11-30 Exercise |
2020-12-02 5:01 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Huang Jane CMO, Hematology |
1,500 | $29.49 | 629,658 (Direct) |
View |
| 2020-11-30 Exercise |
2020-12-02 5:01 pm |
N/A 2026-09-02 |
BeiGene Ltd. | BGNE | Huang Jane CMO, Hematology |
19,500 | $0 | 629,658 (Direct) |
View |
| 2020-10-29 Exercise |
2020-11-02 4:44 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Huang Jane CMO, Hematology |
1,500 | $29.49 | 649,158 (Direct) |
View |
| 2020-10-29 Exercise |
2020-11-02 4:44 pm |
N/A 2026-09-02 |
BeiGene Ltd. | BGNE | Huang Jane CMO, Hematology |
19,500 | $0 | 649,158 (Direct) |
View |
| 2020-10-05 Exercise |
2020-10-07 4:50 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Liang Howard CFO & Chief Strategy Officer |
14,000 | $6.5 | 3,599,415 (Direct) |
View |
| 2020-10-05 Exercise |
2020-10-07 4:50 pm |
N/A 2025-07-01 |
BeiGene Ltd. | BGNE | Liang Howard CFO & Chief Strategy Officer |
182,000 | $0 | 3,599,415 (Direct) |
View |
| 2020-09-29 Exercise |
2020-10-01 4:52 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Huang Jane CMO, Hematology |
1,500 | $29.49 | 668,658 (Direct) |
View |
| 2020-09-29 Exercise |
2020-10-01 4:52 pm |
N/A 2026-09-02 |
BeiGene Ltd. | BGNE | Huang Jane CMO, Hematology |
19,500 | $0 | 668,658 (Direct) |
View |
| 2020-09-14 Exercise |
2020-09-16 5:10 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Liang Howard CFO & Chief Strategy Officer |
14,000 | $6.5 | 3,781,415 (Direct) |
View |
| 2020-09-14 Exercise |
2020-09-16 5:10 pm |
N/A 2025-07-01 |
BeiGene Ltd. | BGNE | Liang Howard CFO & Chief Strategy Officer |
182,000 | $0 | 3,781,415 (Direct) |
View |
| 2020-08-28 Exercise |
2020-09-01 4:41 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Huang Jane CMO, Hematology |
3,000 | $29.49 | 728,822 (Direct) |
View |
| 2020-08-28 Exercise |
2020-09-01 4:41 pm |
N/A 2026-09-02 |
BeiGene Ltd. | BGNE | Huang Jane CMO, Hematology |
39,000 | $0 | 728,822 (Direct) |
View |
| 2020-08-24 Option Award |
2020-08-26 4:51 pm |
N/A 2030-08-23 |
BeiGene Ltd. | BGNE | Sanders Corazon (Corsee) D. Director |
27,482 | $0 | 27,482 (Direct) |
View |
| 2020-08-25 Option Award |
2020-08-25 5:55 pm |
N/A N/A |
BeiGene Ltd. | BGNE | AMGEN INC 10% Owner |
59,390 | $248.49 | 18,524,373 (Direct) |
View |
| 2020-08-21 Option Award |
2020-08-24 5:47 pm |
N/A N/A |
BeiGene Ltd. | BGNE | AMGEN INC 10% Owner |
64,176 | $230.18 | 18,464,983 (Direct) |
View |
| 2020-08-24 Option Award |
2020-08-24 5:47 pm |
N/A N/A |
BeiGene Ltd. | BGNE | AMGEN INC 10% Owner |
59,390 | $239.1 | 18,464,983 (Direct) |
View |
| 2020-08-20 Option Award |
2020-08-20 7:28 pm |
N/A N/A |
BeiGene Ltd. | BGNE | AMGEN INC 10% Owner |
64,176 | $234.99 | 18,341,417 (Direct) |
View |
| 2020-08-19 Option Award |
2020-08-20 7:28 pm |
N/A N/A |
BeiGene Ltd. | BGNE | AMGEN INC 10% Owner |
64,176 | $234.88 | 18,341,417 (Direct) |
View |
| 2020-08-18 Option Award |
2020-08-20 7:28 pm |
N/A N/A |
BeiGene Ltd. | BGNE | AMGEN INC 10% Owner |
40,000 | $230.18 | 18,341,417 (Direct) |
View |